Cromos Pharma, where the patients are

Global News

Drug developers use new models and methods to boost clinical success rates

Thursday, April 17, 2014 11:21 AM

Drug companies and their development partners seeking to increase clinical trial success rates of new drug candidates are developing tools to help them predict the likelihood of marketing approval and incorporating business planning earlier in clinical development, according to R&D leaders who recently participated in a roundtable discussion convened by the Tufts Center for the Study of Drug Development (CSDD).

More... »

CRF Health eCOA webinar series

Report: Anti-counterfeit packaging market to reach $142.7B by 2020

Thursday, April 17, 2014 11:20 AM

According to a new report by Allied Market Research titled Anti-counterfeit Packaging Market in Food and Pharmaceuticals—Technologies, Applications and Global Forecast through 2020, the global anti-counterfeit packaging market in food and pharmaceuticals is forecast to attain market value of $142.7 billion by 2020, from $57.4 billion in 2013, growing at 13.9% CAGR from 2013 to 2020. Technological advancements and government initiatives to curb counterfeiting is expected to drive the market growth.

More... »


Triclinium, Acquipharma collaborate to grow Africa’s clinical research

Thursday, April 17, 2014 11:18 AM

Triclinium Clinical Research, Africa’s largest independent niche CRO, and holding company Acquipharma, have merged to extend clinical research and development business activities in sub-Saharan Africa and other emerging markets. Under the shared umbrella of Acquipharma, Triclinium will collaborate with Cytespace Africa, a Pretoria-based site solutions organization (SSO).

More... »

Theorem Clinical Research, Medidata Solutions expand partnership

Thursday, April 17, 2014 11:15 AM

CRO Theorem Clinical Research recently expanded its Medidata partnership by obtaining accreditation for Medidata Patient Cloud. Medidata Solutions is a global provider of cloud-based solutions for clinical research in life sciences.

More... »

Kineta, RLB Holdings form joint venture for high-need therapeutics

Wednesday, April 16, 2014 01:43 PM

Kineta, a biotechnology company focused on the development of immune-modulating drugs for critical diseases, and RLB Holdings, an investment fund founded by Ray and Lydia Bartoszek, have formed a joint venture, Kineta RLB, which will commercialize promising, high-value compounds in selective disease areas with unmet medical needs.

More... »

Bio-Techne to acquire Shanghai PrimeGene Bio-Tech

Wednesday, April 16, 2014 01:40 PM

Techne, a developer, manufacturer and seller of biotechnology products and clinical controls, has announced that its R&D systems China subsidiary, a specialty manufacturer of biological products, has entered into an agreement to acquire 100% of Shanghai PrimeGene Bio-Tech.

More... »

inVentiv Health Clinical hired by IntelliCell Biosciences for Osteoarthritis IND

Wednesday, April 16, 2014 01:39 PM

CRO inVentiv Health Clinical has been selected for an osteoarthritis Investigational New Drug application (IND) by regenerative medicine biotechnology company IntelliCell BioSciences. IntelliCell will be studying the use of adult autologous vascular cells from blood vessels in adipose tissue to treat osteoarthritis of the knee.

More... »

Cromsource expands European headquarters, opens new office

Wednesday, April 16, 2014 01:26 PM

International CRO Cromsource has opened a new office in Verona, Italy. The building expands its European headquarters.

More... »

BioAlliance Pharma, Topotarget to merge

Wednesday, April 16, 2014 01:18 PM

BioAlliance Pharma, an innovative company specialized in developing drugs within orphan oncology diseases, and Topotarget, a Scandinavian-based biopharmaceutical company, intend to merge to create an orphan oncology company with highly complementary pipelines of late-stage products addressing significant unmet medical needs.

More... »

Catalent, Zhejiang Hisun Pharma to collaborate on biosimilar development

Monday, April 14, 2014 03:05 PM

Catalent Pharma Solutions, a global provider of development solutions and advanced delivery technologies for drug, biologic and consumer health products, has signed an agreement with Zhejiang HISUN Pharmaceuticals to provide HISUN with a broad range of biosimilar cell lines, using Catalent's proprietary GPEx technology for the Chinese market. The development and manufacturing programs will benefit from the GPEx technology's proven capability to produce very stable and high-yielding cell lines.

More... »

`
CenterWatch Data Library
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

April 14

Proposal calls for back-to-back trials to measure efficacy and effectiveness prior to FDA approval

Study: Minority populations under-represented in cancer trials, but have higher rates of incidence

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

April

Make way for mobile health in clinical trials
Despite patient retention, data quality benefits, regulatory hurdles persist

Global clinical trial laboratories decentralize
Regional labs reducing complexity, delivering cost and time savings

Already a subscriber?
Log in to your digital subscription.

Purchase the April issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

March

Strategic alliances hit bumps in the road
Mixed relationship performance driving new approaches

Tapping community hospitals for clinical trial volunteers
New study finds high potential but infrastructure, resources are lacking

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs